Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
World Health Organization urges scale-up of HIV self-testing

HIV self-testing (sometimes called ‘home testing’) should be offered as an additional approach to HIV testing services, the World Health Organization (WHO) recommends in new guidelines issued

Published
29 November 2016
By
Roger Pebody
Closing the HIV prevention investment gap

With funding for prevention falling behind funding for treatment, fewer than one in five people at higher risk of HIV infection today have access to prevention programmes. Inadequate investments in prevention and unfocused investments that do not reach the most affected populations and locations are among the reasons for the prevention gap.

Published
29 November 2016
From
UNAIDS
DAA treatment restricted for Canadian hepatitis C patients

Patients infected by hepatitis C virus (HCV) in Canada have limited access to direct-acting antiviral (DAA) agents, according to a new study. For example, 85% to 92% of the provinces and territories in Canada restrict access to these medications to persons with moderate fibrosis.

Published
29 November 2016
From
Medical Economics
The reinvention of radical protest: life on the frontline of the Aids epidemic

An extract from David France's new book How to Survive a Plague.

Published
29 November 2016
From
The Guardian
Number of HIV-infected Russians receiving free treatment quintuples in 10 years

The amount of HIV-infected Russians who receive free treatment and are under doctors’ care has surged fivefold in Russia over the past 10 years, Russian Health Minister Veronika Skvortsova stated at the opening ceremony of the Second All-Russian Forum for the Prevention and Treatment of HIV and AIDS on Monday.

Published
29 November 2016
From
TASS
Gilead's HIV Business Is More Cash Cow Than Shining Star

Gilead's market share will remain stable or increase in next few years as a result of TAF single tablet regimens. However, market share will decrease in long term as generics, new STRs, further PrEP drugs, new drug classes, and long-acting treatment becomes available. Gilead to decrease pipeline focus on HIV.

Published
28 November 2016
From
Seeking Alpha
Mitchell Warren: We just don't know what President Trump will do on HIV, but 'the signs are worrisome'

During the US election campaign, plenty was said about emails and sexual harassment. But there was little or no talk on global health or HIV. That has left Mitchell Warren, the head of advocates AVAC, worried.

Published
25 November 2016
From
DW
How Much of a Disaster Will Trump's Drug Policies Be?

Those of us who care about helping people with addiction and using science to guide more humane approaches to drugs should be bracing for a tough fight ahead.

Published
24 November 2016
From
Vice
UNAIDS: Young African women are especially vulnerable to HIV/AIDS

The annual World AIDS Day report of the Joint United Nations Programme on HIV/AIDS (UNAIDS) offers a far more nuanced take on the epidemic than it has in previous years. For the first time, the report examines the disease in four age brackets that it calls “the life-cycle approach to HIV.” UNAIDS suggests this breakdown—0 to 14, 15 to 24, 25 to 49, and 50-plus—should lead to a clearer view of the epidemic’s “complex dynamics” and a more targeted response.

Published
23 November 2016
From
Science
Could the FDA be dismantled under Trump?

Has President-elect Donald Trump put a bull’s-eye on the Food and Drug Administration? The agency is facing post-election upheaval. Public health advocates are bracing for a seismic shift: a surrender of the agency’s rules for off-label promotion of drugs; the importation of more drugs from other countries; and fewer requirements for clinical trials.

Published
22 November 2016
From
STAT

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.